Summary
Tonix Pharmaceuticals Holding Corp (Tonix), formerly Tamandare Explorations Inc. is a pharmaceutical company that offers drugs and medicines. The company develops pharmaceutical products and treatments for disorders of the central nervous system such as fibromyalgia, post traumatic stress disorder and episodic tension-type headache. Its products include TNX-102 SL and Tonmya. Tonix’s TNX-102 SL product is a dose and formulation of cyclobenzaprine and is used for the treatment of fibromyalgia and post-traumatic stress disorder. Its tonmya is a formulation provided as cyclobenzaprine HCl sublingual tablets. It sells its products through a network of distributors across the US. Tonix is headquartered in New York, the US.
Tonix Pharmaceuticals Holding Corp (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Tonix Pharma Secures US$0.15 Million In Venture Financing 10
Partnerships 11
Tonix Pharma Enters into Agreement with U.S. Army Medical Materiel Development Activity 11
Equity Offering 12
Tonix Pharma Raises USD5.2 Million in Public Offering of Units 12
Tonix Pharma Raises Funds in Private Placement of Shares 14
Tonix Pharma Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering of Shares for USD1.5 Million 15
Tonix Pharma Raises USD20.1 Million in Public Offering of Shares 17
Tonix Pharma Raises USD28.7 Million in Public Offering of Shares 19
Tonix Pharma to Raise USD8 Million in Private Placement of Shares 21
Tonix Pharma Completes Public Offering Of Shares For US$43.5 Million 23
Tonix Pharma Completes Public Offering Of Units For US$11.4 Million 25
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$1 Million 27
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$2.3 Million 29
Debt Offering 30
Tonix Pharmaceuticals Completes Private Placement Of Notes Due 2013 For US$1 Million 30
Acquisition 31
Tamandare Explorations Acquires TONIX Pharma 31
Tonix Pharmaceuticals Holding Corp - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Tonix Pharmaceuticals Holding Corp, Deals By Therapy Area, 2010 to YTD 2016 8
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Tonix Pharma Secures US$0.15 Million In Venture Financing 10
Tonix Pharma Enters into Agreement with U.S. Army Medical Materiel Development Activity 11
Tonix Pharma Raises USD5.2 Million in Public Offering of Units 12
Tonix Pharma Raises Funds in Private Placement of Shares 14
Tonix Pharma Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering of Shares for USD1.5 Million 15
Tonix Pharma Raises USD20.1 Million in Public Offering of Shares 17
Tonix Pharma Raises USD28.7 Million in Public Offering of Shares 19
Tonix Pharma to Raise USD8 Million in Private Placement of Shares 21
Tonix Pharma Completes Public Offering Of Shares For US$43.5 Million 23
Tonix Pharma Completes Public Offering Of Units For US$11.4 Million 25
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$1 Million 27
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$2.3 Million 29
Tonix Pharmaceuticals Completes Private Placement Of Notes Due 2013 For US$1 Million 30
Tamandare Explorations Acquires TONIX Pharma 31
Tonix Pharmaceuticals Holding Corp, Key Competitors 32
Tonix Pharmaceuticals Holding Corp, Key Employees 33
Tonix Pharmaceuticals Holding Corp, Other Locations 34
Tonix Pharmaceuticals Holding Corp, Subsidiaries 34
List of Figures
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
